| GERON CORP. (DEL.) DL-001 |
| USA |
| Gesundheit |
| US3741631036 / 902213 |
| GON (Frankfurt) / GERN (NASDAQ) |
| FRA:GON, ETR:GON, GON:GR, NASDAQ:GERN |
| - |
| https://www.geron.com/ |
|
Geron Corporation is a biopharmaceutical company d..
>Volltext.. |
| 863.7 Mio. EUR |
| 751.79 Mio. EUR |
| 154.13 Mio. EUR |
| -51.98 Mio. EUR |
| -67.22 Mio. EUR |
| -0.1 EUR |
| 211.14 Mio. EUR |
| 67.22 Mio. EUR |
| -111.7 Mio. EUR |
| 4.36 |
| 490.3% |
| 62.28% |
| - |
| - |
| - |
| - |
| GERON |
| 11.02.26 |
|
||||
|